SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john who wrote (9)2/25/1998 4:48:00 PM
From: Pseudo Biologist  Read Replies (2) of 415
 
Competitors. As stated before Cubist is the obvious "pure play" competitor, but there are a few more.

Genome Therapeutics (GENE) has programs in the area. See for example cric.com So do some of the other genomics companies at some levels (INCY, MLNM, HGSI)

Xoma is sort of a player thru their BPI platform, as it is claimed to potentiate existing antibiotics. In particular, rBPI121 enhances antibiotic activity in vivo and in vitro, and can overcome resistance to these antibiotics in vitro. BPI, however, is a protein and thus not orally available as a pill or capsule.

There is an outfit called SIGA Pharmaceuticals (SGPH) working on bacterial adhesion as a new target for antibiotic development. They recently signed a technology deal with MedImmune and Washington University (St. Louis). Here is link for quick reference biz.yahoo.com

SynPhar Laboratories (Canada) claims to have a novel, potent beta-lactamase inhibitor (sounds like a "me too" drug to me, but have not looked much further). Here is another quick link edt.gov.ab.ca

A ~50/50 unit of Sepracor (SEPR), Versicor, is engaged in a program that, to some degree, looks similar to MCDE's. Versicor also has an agreement with GENE: cric.com

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News